Frederick A. Brookfield
Evotec (United Kingdom) · 19 works · 736 citations · h-index 12
Top works
- Binding Mode and Structure–Activity Relationships around Direct Inhibitors of the Nrf2–Keap1 Complex
- Identification of L-Tryptophan Derivatives with Potent and Selective Antagonist Activity at the NK1 Receptor
- Phthalazinone Pyrazoles as Potent, Selective, and Orally Bioavailable Inhibitors of Aurora-A Kinase
- Indole-3-acetic Acid Antagonists of the Prostaglandin D2 Receptor CRTH2
- Discovery and Structure–Activity Relationship of Potent and Selective Covalent Inhibitors of Transglutaminase 2 for Huntington’s Disease
- Novel modified tripeptide inhibitors of α4β7 mediated lymphoid cell adhesion to MAdCAM-1
- Fragment Molecular Orbital Method Applied to Lead Optimization of Novel Interleukin-2 Inducible T-Cell Kinase (ITK) Inhibitors
- Development of a Series of Aryl Pyrimidine Kynurenine Monooxygenase Inhibitors as Potential Therapeutic Agents for the Treatment of Huntington’s Disease
- Thiazole formation via traceless cleavage of Rink resin
- The carboxyterminal processing protease of D1 protein: Herbicidal activity of novel inhibitors of the recombinant and native spinach enzymes
- Exploiting differences in caspase-2 and -3 S2 subsites for selectivity: Structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors
- SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease
- Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease
- Design, synthesis and structure–activity relationships of a novel class of sulfonylpyridine inhibitors of Interleukin-2 inducible T-cell kinase (ITK)
- Inside Cover: Binding Mode and Structure–Activity Relationships around Direct Inhibitors of the Nrf2–Keap1 Complex (ChemMedChem 4/2014)
- Abstract ND04: BAY 2666605: The first PDE3A-SLFN12 complex inducer for cancer therapy
- Structure of keap1 kelch domain with (1S,2R)-2-{[(1S)-1-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-3,4-dihydroisoquinolin-2(1H)-yl]carbonyl}cyclohexanecarboxylic acid
- ChemInform Abstract: Novel Modified Tripeptide Inhibitors of α4β7 Mediated Lymphoid Cell Adhesion to MAdCAM‐1.
- Structure of keap1 kelch domain with 2-{[(1S)-2-{[(1R,2S)-2-(1H-tetrazol-5-yl)cyclohexyl]carbonyl}-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-1H-isoindole-1,3(2H)-dione